{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-053654","form_type":"8-K","ticker":"RNLXY","cik":"0001811115","company_name":"Renalytix plc","filed_at":"2023-10-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.589829+00:00","generated_at":"2026-06-09T22:44:50.073632+00:00","sec_items":["7.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Renalytix repays $1.06M of convertible bond with equity, principal now $14.84M","bullets":["Repaid $1.06 million of convertible bond via 150,000 ordinary shares and 1,092,694 ADSs.","Remaining convertible bond principal reduced to $14.84 million.","Total shares outstanding after admission: 97,430,156 ordinary shares.","New ordinary shares expected to be admitted to AIM on October 19, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-053654","json":"https://secwatch.observer/filing/0000950170-23-053654.json","markdown":"https://secwatch.observer/filing/0000950170-23-053654.md","text":"https://secwatch.observer/filing/0000950170-23-053654.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1811115/000095017023053654/0000950170-23-053654-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1811115/000095017023053654/rnlx-20231017.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T22:44:50.073632+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}